U.S.-China Groups To Work Together On Pharma Quality Control
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Shanghai Institute for Food and Drug Safety and the Parenteral Drug Association signed a memorandum of understanding earlier this month to accelerate and improve the quality of pharmaceutical manufacturing in China through enhanced international cooperation
You may also be interested in...
Focused On Globalization, Shanghai FDA Will Hold International Forum On Drug Safety And Regulatory Change
BEIJING - In an effort to fast-forward the globalization of China's drug laws and utlimately boost its exports of pharmaceuticals, the Shanghai FDA is partnering with a U.S.-based law firm to co-host its first international forum on drug safety and regulatory change
Focused On Globalization, Shanghai FDA Will Hold International Forum On Drug Safety And Regulatory Change
BEIJING - In an effort to fast-forward the globalization of China's drug laws and utlimately boost its exports of pharmaceuticals, the Shanghai FDA is partnering with a U.S.-based law firm to co-host its first international forum on drug safety and regulatory change
Shanghai FDA Signs Agreement With U.S. Law Firm To Foster International Cooperation on Drug Regulation
BEIJING - A new government think tank focused on health-sector regulatory reform and international cooperation set up by the Shanghai FDA will work closely with a U.S.-based law firm to review drug laws worldwide and to host a series of global exchanges